肝癌肝动脉栓塞用载药微球的研究现状及进展

doi:10.3969/j.issn.1671-7171.2017.02.043

Abstract
Figure/Table
References
Related Citation (15)

[1] Turkbey B, Choyke PL. Multiparametric MRI and prostate cancer diagnosis and risk stratification[J].Curr Opin Urol,2012,22(4):310-315.
[2] Vargas HA, Hotker AM, Goldman A,et al. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference[J].Eur Radiol,2016,26(6):1606-1612.
[3] Scialpi M, Falcone G, Scialpi P, et al. Biparametric MRI: a further improvement to PIRADS 2.0[J].Diagn Interv Radiol,2016,22(3):297-298.
[4] Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012[J].Eur Radiol,2012,22(4):746-757.
[5] Bomers JG, Barentsz JO. Standardization of multiparametric prostate MR imaging using PI-RADS[J].Biomed Res Int,2014,2014:431680.
[6] Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate Imaging -Reporting and Data System: 2015, Version 2[J].Eur Urol,2016,69(1):16-40.
[7] Barentsz JO, Weinreb JC, Verma S, et al. Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use[J].Eur Urol,2016,69(1):41-49.
[8] Greer MD, Brown AM, Shih JH, et al. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study[J].J Magn Reson Imaging,2017,45(2):579-585.
[9] Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting[J].Eur Urol,2011,59(4):477-494.
[10] Siegel C. Re: prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging[J].J Urol,2014,192(1):128-129.
[11] Cornelis F, Rigou G, Le Bras Y, et al. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings[J].Radiology,2013,269(1):159-166.
[12] Johnston R, Wong L M, Warren A, et al. The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer[J].ANZ J Surg,2013,83(4):234-238.
[13] Ploussard G, Epstein JI, Montironi R, et al. The contemporary concept of significant versus insignificant prostate cancer[J].Eur Urol,2011,60(2):291-303.